INSTITUT CURIE;ABIVAX;CENTRE NATIONALE DE RECHERCHE SCIENTIFIQUE;UNIVERSITE MONTPELLIER 2
发明人:
Pierre Roux,Florence Mahuteau,Romain Najman,Jamal Tazi,Gilles Gadea,Didier Scherrer,Carsten Brock,Nathalie Cahuzac
申请号：
US14789149
公开号：
US09637475B2
申请日:
2015.07.01
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A method of preventing, inhibiting, or treating cancer that includes contacting a cell with at least one compound of formula (Ia) or a pharmaceutically acceptable salt thereof:where:R independently represents a hydrogen atom, a halogen atom, a (C1-C3)alkyl group, a —CN group, a hydroxyl group, a —COOR1 group, a (C1-C3)fluoroalkyl group, a —NO2 group, a —NR1R2 group, or a (C1-C3)alkoxy group；R′ is a hydrogen atom, a halogen atom, a (C1-C3)alkyl group, a —NO2 group, a (C1-C3)alkoxy group, or a —NR1R2 group； andR1 and R2 are a hydrogen atom or a (C1-C3)alkyl group.
